Literature DB >> 14437338

Obesity in childhood: a clinical trial of phenmetrazine.

J RENDLE-SHORT.   

Abstract

Entities:  

Keywords:  OBESITY/in infancy and childhood; PHENMETRAZINE/therapy

Mesh：

Substances：

Year:  1960        PMID： 14437338      PMCID： PMC1966663          DOI： 10.1136/bmj.1.5174.703

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Subacute delirious state due to preludin addiction.

Authors:  M SILVERMAN
Journal:  Br Med J       Date:  1959-03-14

2.  The use of phenmetrazine hydrochloride (preludin) in the obese diabetic.

Authors:  W LEITH; J C BECK
Journal:  Can Med Assoc J       Date:  1958-12-01       Impact factor: 8.262

3.  A study of the effectiveness of certain anorexigenic agents.

Authors:  J F FAZEKAS; W R EHRMANTRAUT; J KLEH
Journal:  Am J Med Sci       Date:  1958-12       Impact factor: 2.378

4.  Psychosis and addiction to phenmetrazine (preludin).

Authors:  J EVANS
Journal:  Lancet       Date:  1959-08-22       Impact factor: 79.321

5.  A comparative study of phenmetrazine and dextro-amphetamine in a short-term reducing program in medical students.

Authors:  M PATTERSON
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1959-04

6.  Toxic psychosis caused by preludin.

Authors:  M F BETHELL
Journal:  Br Med J       Date:  1957-01-05

7.  [Experience with preludin in the treatment of adipositas and enuresis in children].

Authors: 
Journal:  Med Monatsschr       Date:  1955-06
  7 in total
  2 in total

1.  Phenmetrazine hydrochloride in treatment of obesity.

Authors:  J H BRIGGS; P M NEWLAND; P M BISHOP
Journal:  Br Med J       Date:  1960-09-24

2.  The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine.

Authors:  Anushree N Karkhanis; Thomas J R Beveridge; Bruce E Blough; Sara R Jones; Mark J Ferris
Journal:  Drug Alcohol Depend       Date:  2016-06-25       Impact factor: 4.492
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.